Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 22;58(12):1701.
doi: 10.3390/medicina58121701.

Impact of the COVID-19 Pandemic on the Outcomes of Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: A Single Center Experience from a Developing Country

Aleksandar Filipović  1   2 , Dragan Mašulović  1   2 , Marko Živanović  3 , Tamara Filipović  1   4 , Dušan Bulatović  2 , Miloš Zakošek  2 , Dejan Nikolić  1   5 , Danijel Galun  1   3
Affiliations

Impact of the COVID-19 Pandemic on the Outcomes of Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: A Single Center Experience from a Developing Country

Aleksandar Filipović et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Treatment of cancer patients during the COVID-19 pandemic has been a challenge worldwide. In accordance with the current recommendations for hepatocellular carcinoma (HCC) management during the COVID-19 pandemic, loco-regional therapy such as transarterial chemoembolization (TACE) was proposed with the purpose of achieving local tumor control and improving overall survival. The aim of this prospective cohort study was to evaluate the outcomes of TACE treatment in patients with HCC during the COVID-19 pandemic in comparison with the outcomes of patients treated in the pre-pandemic period. Materials and Methods: Between September 2018 and December 2021, 154 patients were managed by serial TACE procedures for different liver tumors. Ninety-seven patients met the study criteria and were divided into two groups: the study group n = 49 (patients treated from May 2020 to December 2021); the control group n = 48 (patients treated from September 2018 to May 2020). Results: The mean waiting time for TACE was significantly longer in the study group compared to the control group (p < 0.001). No significant difference in survival between the groups is noted (log-rank test p = 0.823). In multivariate analysis, the MELD score (HR 1.329, 95% CI 1.140−1.548, p < 0.001) remained a significant predictor of mortality. Conclusions: COVID-19 pandemic did not affect the final outcome of TACE treatment.

Keywords: COVID-19; hepatocellular carcinoma; loco-regional therapy; survival; transarterial chemoembolization.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patients Flowchart.
Figure 2
Figure 2
Overall survival of HCC patients treated by TACE.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Cortiula F., Pettke A., Bartoletti M., Puglisi F., Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann. Oncol. 2020;31:553–555. doi: 10.1016/j.annonc.2020.03.286. - DOI - PMC - PubMed
    1. Denys A., Guiu B., Chevallier P., Digklia A., de Kerviler E., de Baere T. Interventional oncology at the time of COVID-19 pandemic: Problems and solutions. Diagn. Interv. Imaging. 2020;101:347–353. doi: 10.1016/j.diii.2020.04.005. - DOI - PMC - PubMed
    1. Mureșan A.V., Russu E., Arbănași E.M., Kaller R., Hosu I., Arbănași E.M., Voidăzan S.T. Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania. J. Clin. Med. 2022;11:2452. doi: 10.3390/jcm11092452. - DOI - PMC - PubMed
    1. Emil-Marian A., Reka K., Adrian M.V., Septimiu V., Eliza-Mihaela A., Eliza R. Impact of COVID-19 pandemic on Vascular Surgery Unit activity in Central Romania. Front. Surg. 2022;9:883935. doi: 10.3389/fsurg.2022.883935. - DOI - PMC - PubMed
    1. Morgan R., Arabi M., Arai Y., Das M., Golzarian J., Holden A., Roy-Choudhury S.H., Spiliopoulos S., Teng G.-J., Tsitskari M. IR voices about COVID 19. CVIR Endovasc. 2020;3:45. doi: 10.1186/s42155-020-00136-z. - DOI - PMC - PubMed